Introducing our new design

Article

Contemporary OB/GYN introduces its new, easier-to-read design.


We often hear that Contemporary OB/GYN is “easy to read.” That’s because we publish peer-reviewed review articles (rather than original research) to provide clinically useful information in an easily digestible format. All the key studies on a topic are synthesized by an expert in the field, so readers know they’re getting trustworthy guidance for clinical practice.

With this redesign, we set out to make visual design changes driven by our knowledge of our readers and what you like best about the magazine. The tables and figures are cleaner and more defined, and the fonts are more contemporary. We’ve selected visuals that point to the essence of each article.

I think you’ll find that our new cleaner design makes our content even easier to read and use in your day-to-day practice.

-Charles J Lockwood, MD, MHCM, Editor-in-Chief

To view an interview with Dr. Lockwood and Art Director Nicole Davis-Slocum, visit the Contemporary OB/GYN YouTube channel: https://www.youtube.com/watch?v=xSHI4-jp9fo

 

 

NEXT:  Before and after

 

The design of the peer-reviewed features you're used to seeing in Contemporary OB/GYN has been kicked up a notch. The tables and figures are much easier to read. We're including more facts and data in graphic format to make them really stand out. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recent Videos
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Lauren Streicher, MD
© 2024 MJH Life Sciences

All rights reserved.